Cross-Coupling Reactions
FULL PAPER
ed a colorless solid. Recrystallization from hexane gave fraction I: 83 mg
(540 mg, 13.5 mmol) in THF/toluene (1:1, 36 mL) at 1008C for 24 h.
Column chromatography on silica gel [100 g, pentane/diethyl ether
(20:1), column 2.535 cm] gave fraction I: 1,10-dimethylthio-3,3,8,8-te-
(
55%) of pentakis(2-tert-pentylethenyl)benzene (21e) as colorless crys-
tals. M.p. 1878C; IR (KBr): n˜ =3029 (CÀH), 2953, 2861 (CÀH), 1472,
À1
1
1
0
425, 1282, 1254, 973, 851 cm
;
H NMR (250 MHz, CDCl
], 1.37–1.43 (m, 10H, CH
.58 (d, J=16.6 Hz, 2H, 2’-H*), 5.60 (d, J=16.4 Hz, 1H, 2’-H), 5.96 (d,
3
): d=0.81–
tramethyldeca-4,6-diene (22g) as a colorless solid (61 mg, 4.3%). R
f
=
.88 (m, 15H, 5’-H), 1.05 [brs, 30H, C(CH
3
)
2
2
),
0.65; IR (KBr): n˜ =3025 (CÀH), 2960, 2913, 2851 (CÀH), 1457, 1380,
3
3
À1
1
5
1363, 1314, 1261, 1240, 1001, 802 cm ; H NMR (250 MHz, CDCl
3
): d=
3
3
3
J=16.1 Hz, 2H, 2’-H*), 6.18 (d, J=16.4 Hz, 1H, 1’-H), 6.24 (d, J=
1.02[s, 12H, C(CH ], 1.59 [m, 4H, 2(9)-H], 2.09 (s, 6H, SCH ), 2.39 [m,
3
)
2
3
3
1
6.6 Hz, 2H, 1’-H*), 6.54 (d, J=16.1 Hz, 2H, 1’-H*), 7.42ppm (s, 1H,
4H, 1(10)-H], 5.53 [AA’ part of an AA’BB’ system, 2H, 4(7)-H],
1
3
13
Ph-H); C NMR (62.9 MHz, CDCl
C-5’*), 9.3 (+, 1C, C-5’*), 9.3 (+, 2C, C-5’*), 26.7 [+, 4 C, C(CH
6.8 [+, 2 C, C (C H ], 26.8 [+, 4C, C(CH
], 35.3 (À, 1C, C-4’*), 35.3
À, 2C, C-4’*), 35.8 (À, 2C, C-4’*), 36.7 (Cquat, 2C, C-3’*), 36.9 (Cquat, 1C,
C-3’*), 37.1 (Cquat, 2C, C-3’*), 123.1 (+, 1C, C-2’*), 124.0 (+, 2C, C-2’*),
24.7 (+, 1C, Ph-C), 126.8 (+, 2C, C-2’*), 134.1 (Cquat, 2C, Ph-C), 134.9
3
, additional DEPT): d=9.2( +, 2 C,
5.92ppm [BB ’ part of an AA’BB’ system, 2H, 5(6)-H]; C NMR
)
2
],
(62.9 MHz, CDCl
3 3
, additional DEPT): d=15.6 (+, SCH ), 27.1 [+,
3
2
(
3
)
2
3
)
2
C(CH
3 2
)
], 29.8 [À, C-1(10)], 36.2[C quat, C-3(8)], 42.7 [À, C-2(9)], 127.2
[+, C-4(7)], 141.4 ppm [+, C-5(6)]; MS (70 eV): m/z (%): 288/287/286
+
+
(10/16/100) [M] , 271 (14) [MÀCH
3
] , 211 (30), 107 (18), 75 (70), 61 (28)
(286.6): C 67.07, H
+
1
[C
2
H
5
S] ; elemental analysis calcd (%) for C16
H
30
S
2
(
1
6
C
quat, 2C, Ph-C), 136.4 (Cquat, 1C, Ph-C), 139.7 (+, 2C, C-1’*), 145.6 (+,
10.55; found C 67.01, H 10.39. Fraction II: 50 mg of a pale yellow oil
1
C, C-1’*), 145.8 ppm (+, 2C, C-1’*); MS (70 eV): m/z (%): 559/558 (26/
0) [M] , 462(100), 417 (100), 363 (80), 3 21 (85), 71 (90); HRMS: m/z:
(R
duction products. Fraction III: pentakis[(E)-3’,3’-dimethyl-5’-methylthio-
1’-pentenyl]benzene (21g) as a colorless solid (148 mg, 38%). R =0.30;
IR (KBr): n˜ =3024, 2958, 2914, 2865, 1652, 1472, 1437, 1383, 1361, 1253,
f
=0.41) which, according to its H NMR spectrum was a mixture of re-
+
calcd for C41
H
66 (559.0): 558.5164, found 558.5164. Fraction II: 18 mg
f
(
2
10%) of 1e as colorless crystals. M.p. 2638C; IR (KBr): n˜ =2945 (CÀH),
À1
1
À1 1
867 (CÀH), 1762, 1461, 1412, 1364, 1209, 965, 911 cm
; H NMR
9
72cm
;
H NMR (250 MHz, CDCl
3
): d=1.13 [brs, 30H, C(CH
3 2
) ],
3
1
.63–1.73 (m, 10H, 4’-H), 2.09 (brs, 15H, SCH
3
), 2.41–2.56 (m, 10H, 5’-
(
250 MHz, CDCl
3
): d=0.84 (t, J=7.5 Hz, 18H, 5’-H), 1.04 [s, 36H,
3
3
3
3
H), 5.57 (d, J=16.5 Hz, 2H, 2’*-H), 5.59 (d, J=16.5 Hz, 1H, 2’-H), 5.98
(d, J=16.2Hz, 2H, 2 ’*-H), 6.17 (d, J=16.5 Hz, 1H, 1’-H), 6.24 (d, J=
3 2
C(CH ) ], 1.36 (q, J=7.5 Hz, 12H, 4’-H), 5.50 (d, J=16.5 Hz, 6H, 2’-
H), 6.22 ppm (d, J=16.5 Hz, 6H, 1’-H); C NMR (125.7 MHz, CDCl
additional DEPT): d=9.2( +, C-5’), 26.6 [+, C(CH
3
1
3
3
3
3
13
3
,
3
1
6.5 Hz, 2H, 2’**-H), 6.51 (d, J=16.2Hz, 2H, 2 ’**-H), 7.42ppm (s, 1H,
3
)
2
], 35.4 (À, C-4’),
1
3
Ph-H); C NMR (62.9 MHz, CDCl
3
, additional DEPT): d=15.6 (+,
6.7 (Cquat, C-3’), 125.9 (+, C-2’), 135.2(C quat, Ph-C), 144.1 ppm (+, C-
’); MS (70 eV): m/z (%): 655/654 (10/20) [M] , 618 (30), 560 (10), 321
+
SCH ), 15.7 (+, SCH ), 27.2 [+, C(CH ) ], 27.2 [+, C(CH ) ], 30.0 (À,
3
3
3
2
3 2
C-5’), 30.1 (À, C-5’), 36.9 (Cquat, C-3’), 37.1 (Cquat, C-3’), 37.2(C quat, C-3’),
2.6 (À, C-4’), 42.9 (À, C-4’), 123.4 (+, C-2’*), 124.3 (+, C2’*), 125.1 (+,
Ph-C*), 126.9 (+, C2’*), 133.9 (Cquat, Ph-C), 134.8 (Cquat, Ph-C), 136.2
(
100), 71 (90); elemental analysis calcd (%) for C48H78 (655.1): C 88.00,
4
H 12.00; found C 90.02, H 11.92.
Variant 2: According to GP 6, hexabromobenzene (275 mg, 500 mmol)
was treated with 4e (1.05 g, 4.68 mmol) in the presence of dichlorobis(tri-
phenylphosphine)palladium (105 mg, 150 mmol) and powdered sodium
hydroxide (530 mg, 13.3 mmol) in THF/toluene (1:1, 40 mL) at 1008C for
2
5
(
(
Cquat, Ph-C), 139.2( +, C-1’), 145.0 (+, C-1’), 145.3 ppm (+, C-1’); MS
+
70 eV): m/z (%): 790/789/788 (5/11/22) [M] , 673/672/671 (10/18/36)
+
+
+
[
MÀC
6
H
13S] , 117 (78) [C
6
H
13S] , 61 (100) [C
2
H
5
S] ; elemental analysis
calcd (%) for C46
76 5
H S (789.4): C 69.99, H 9.70; found C 70.08, H 9.80.
4 h. Column chromatography on silica gel (40 g, hexane, column 3
0 cm, R =0.48) yielded 225 mg of a colorless solid. Recrystallization
Fraction IV: 102mg ( 22 %) of 1g as a waxy solid. IR (KBr): n˜ =2959,
f
À1
2
916, 2677, 1652, 1472, 1437, 1383, 1363, 1261, 1036, 971, 804 cm
;
from hexane gave fraction I: 207 mg (74%) of 21e. Fraction II: 52mg
16%) of 1e as colorless crystals.
1
H NMR (250 MHz, CDCl
1
1
3
): d=1.10 [s, 36H, C(CH
2H, 4’-H), 2.08 (s, 18H, SCH ), 2.41–2.48 (m, 12H, 5’-H), 5.49 (d, J=
6.5 Hz, 6H, 2’-H), 6.22 ppm (d, J=16.5 Hz, 6H, 1’-H); C NMR
, additional DEPT): d=15.6 (+, SCH ), 26.9 [+,
], 29.9 (À, C-5’), 36.9 (Cquat, C-3’), 42.7 (À, C-4’), 126.1 (+, C-2’),
3 2
) ], 1.61–1.67 (m,
(
3
3
Hexakis-[(E)-6’-methoxy-3’,3’-dimethyl-1’-hexenyl]benzene (1 f): Accord-
ing to GP 6, hexabromobenzene (165 mg, 300 mmol) was treated with 4 f
3
13
(
62.9 MHz, CDCl
3
3
(
805 mg, 3.00 mmol) in the presence of dichlorobis(triphenylphosphine)-
palladium (63 mg, 90 mmol) and powdered sodium hydroxide (324 mg,
.10 mmol) in THF/toluene (1:1, 40 mL) at 1008C for 24 h. Column chro-
matography on silica gel [100 g, pentane/diethyl ether (2:1), column 2.5
5 cm] gave fraction I: 26 mg (3%) of 1,12-dimethoxy-4,4,9,9-tetrame-
3 2
C(CH )
1
9
35.1 (Cquat, Ph-C), 143.6 ppm (+, C-1’); MS (70 eV): m/z (%): 934/933/
8
+
32/931 (5/11/12/20) [M] , 816/815/814/813 (6/12/15/25), 118/117 (28/100)
+
+
[
C
6
H
13S] , 61 (57) [C
2
H
5
S] ; elemental analysis calcd (%) for C54
H
90
S
6
4
(
931.7): C 69.61, H 9.74; found C 69.69, H 9.53.
1
thyldodeca-5,7-diene (22 f) as
250 MHz, CDCl ): d=1.01 [s, 12H, C(CH
.51 [m, 4H, 2(11)-H], 3.34 (s, 6H, OCH ), 3.36 [t, J=7.2Hz, 4H, 1(1 2) -
a
colorless solid.
f
R =0.62; H NMR
Hexakis-[(E)-5’-methoxy-3’,3’-dimethyl-1’-pentenyl]benzene (1h)—Var-
iant 1: According to GP 6, hexabromobenzene (276 mg, 500 mmol) was
treated with 2h (1.23 g, 5.00 mmol) in the presence of dichlorobis(triphe-
nylphosphine)palladium (53 mg, 75 mmol) and powdered sodium hydrox-
ide (540 mg, 13.5 mmol) in THF/toluene (1:1, 36 mL) at 1008C for 24 h.
Column chromatography on silica gel [60 g, pentane/diethyl ether (1:1),
column 2.530 cm]: Fraction I: 53 mg (8.3%) of 1,10-dimethoxy-3,3,8,8-
(
1
3
3 2
)
], 1.26 [m, 4H, 3(10)-H],
3
3
H], 5.54 [AA’ part of an AA’BB’ system, 2H, 5(8)-H], 5.91 ppm [BB’
part of an AA’BB’ system, 2H, 6(7)-H]. Fraction II: 23 mg of a pale
yellow oil (R
mixture of reduction products. Fraction III: 80 mg (34%) of penta-
kis[(E)-5’-methoxy-3’,3’-dimethyl-1’-hexenyl]benzene (21 f) as a colorless
solid.
C(CH
1
f
=0.38) which, according to its H NMR spectrum was a
tetramethyldeca-4,6-diene (22h). R
f
=0.65; M.p. 498C; IR (KBr): n˜ =
1
R
f
=0.26; H NMR (250 MHz, CDCl
3
): d=1.11 [brs, 30H,
), 3.30–3.41
3
1
[
027 (CÀH), 2977, 2922, 2867 (CÀH), 1434, 1376, 1353, 1311, 1257, 1235,
3
)
2
], 1.33–1.61 [m, 20H, 4’(5’)-H], 3.31 (brs, 15H, OCH
3
À1 1
014 cm
;
H NMR (250 MHz, CDCl
3
): d=1.02[s, 1 2H , C(CH
3
)
2
], 1.61
), 3.31 [t, J=7.2Hz, 4H,
(10)-H], 5.54 [AA’ part of an AA’BB’ system, 2H, 4(7)-H], 5.94 ppm
3
3
(
m, 10H, 6’-H), 5.59 (d, J=18.3 Hz, 2H, 2’-H), 5.62(d, J=18.4 Hz, 1H,
3
3
t, J=7.2 Hz, 4H, 2(9)-H], 3.28 (s, 6H, OCH
3
3
3
2
6
’-H), 5.98 (d, J=18.3 Hz, 2H, 2’-H), 6.18 (d, J=18.4 Hz, 1H, 1’-H),
.25 (d, J=18.3 Hz, 2H, 1’-H), 6.56 (d, J=18.3 Hz, 2H, 1’-H), 7.39 ppm
1
3
3
13
[
BB’ part of an AA’BB’ system, 2H, 5(6)-H]; C NMR (62.9 MHz,
CDCl , additional DEPT): d=27.6 [+, C(CH ], 35.0 [Cquat, C-3(8)],
2.0 [À, C-2(9)], 58.5 (+, OCH ), 70.0 [À, C-1(10)], 126.7 [+, C-4(7)],
41.8 ppm [+, C-5(6)]. Fraction II: 51 mg of a pale yellow oil (R =0.45),
(
s, 1H, Ph-H). Fraction IV: 49 mg (18%) of 1 f as a colorless solid. R
f
=
3
3 2
)
0
1
1
1
6
.16; IR (KBr): n˜ =2989, 2936, 2599, 1654, 1447, 1435, 1379, 1345, 1222,
045, 977 cm
.31–1.59 [m, 24H, 4’(5’)-H], 3.30 (s, 18H, OCH
2H, 6’-H), 5.51 (d, J=18.4 Hz, 6H, 2’-H), 6.22 ppm (d, J=18.4 Hz,
H, 1’-H); C NMR (62.9 MHz, CDCl
], 36.3 (À, C-5’), 39.6 (Cquat, C-3’), 58.5 (À, C-6’),
25.9 (+, C-2’), 135.0 (Cquat, Ph-C), 144.1 ppm (+, C1’).
4
1
3
À1
1
;
H NMR (250 MHz, CDCl
3
): d=1.05 [s, 36H, C(CH
3
)
2
],
f
3
), 3.35 (t, J=6.9 Hz,
1
3
according to H NMR spectrum a mixture of reduction products. Fraction
3
3
III: 270 mg (75%) of pentakis[(E)-5’-methoxy-3’,3’-dimethyl-1’-pentenyl]-
1
3
3
, additional DEPT): d=25.1 (À,
benzene (21h). R
472, 1424, 1368, 1224, 972 cm
brs, 30H, C(CH ], 1.68–1.76 (m, 10H, 4’-H), 3.31 (brs, 15H, OCH
3.38–3.47 (m, 10H, 5’-H), 5.60 (d, J=18.3 Hz, 2H, 2’-H), 5.62(d, J=
f
=0,22; IR (KBr): n˜ =3029, 2981, 2921, 2877, 1661,
C-4’), 27.0 [+, C(CH
1
3
)
2
À1
1
1
[
;
H NMR (250 MHz, CDCl
3
): d=1.15
),
3
)
2
3
3
3
Hexakis-[(E)-3’,3’-dimethyl-5’-methylthio-1’-pentenyl]benzene (1g): Ac-
cording to GP 6, hexabromobenzene (276 mg, 500 mmol) was treated
with 4g (1.35 g, 5.00 mmol) in the presence of dichlorobis(triphenylphos-
phine)palladium (105 mg, 150 mmol) and powdered sodium hydroxide
3
3
18.4 Hz, 1H, 2’-H), 6.03 (d, J=18.3 Hz, 2H, 2’-H), 6.18 (d, J=18.4 Hz,
3
3
1H, 1’-H), 6.27 (d, J=18.3 Hz, 2H, 1’-H), 6.55 (d, J=18.3 Hz, 2h, 1 ’-
H), 7.46 ppm (s, 1H, Ph-H); C NMR (62.9 MHz, CDCl
1
3
3
, additional
Chem. Eur. J. 2005, 11, 308 – 320
ꢀ 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
317